118 articles, page 7 of 10
Newest first
Tirzepatide, the active ingredient in Mounjaro and Zepbound, has become one of the most prescribed medications in the country.
By Harbor Health Team
If you have been taking semaglutide, whether as Ozempic for type 2 diabetes or Wegovy for weight loss, and the results have slowed, stopped, or never quite reached where you wanted them, you are far from alone.
By Harbor Health Team
Most people who have heard of tirzepatide know it as Mounjaro or Zepbound.
By Harbor Health Team
For decades, the medical community treated obstructive sleep apnea the same way.
By Harbor Health Team
Most tirzepatide side effects are nausea, diarrhea, constipation, and vomiting.
By Harbor Health Team
Tirzepatide has delivered some of the most dramatic weight loss outcomes in the history of obesity medicine, with reductions of 20% or more in major clinical trials.
By Harbor Health Team
Most people who recognize the name tirzepatide associate it with weight loss.
By Harbor Health Team
Tirzepatide has quickly become one of the most talked-about medications in metabolic care, but for many patients, the biggest challenge is not getting a prescription.
By Harbor Health Team
For years, the question of whether tirzepatide or semaglutide is the better obesity medication relied on indirect comparisons, cross-trial guesswork, and a single diabetes-focused study that used the wrong semaglutide dose for weight loss.
By Harbor Health Team
If you have ever followed a plan perfectly for a few weeks and still felt like your body was fighting you, you are not imagining it.
By Harbor Health Team
After decades of limited success with diet pills and other treatments, the emergence of semaglutide for weight loss is being hailed as a game-changer in obesity care.
By Harbor Health Team
Glucagon-like peptide-1 (GLP-1) receptor agonists have surged in use as powerful treatments for type 2 diabetes and as prescription weight-loss aids.
By Harbor Health Team
